The interleukin-8-251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population

It has been demonstrated that polymorphisms within inflammation-related genes are associated with risk of gastric carcinoma in Helicobacter pylori-infected individuals. Recently, several studies have reported conflicting results regarding the association between the interleukin (IL)8-251*T/*A polymorphism and risk of gastric carcinoma. In this study, we performed a case–control analysis, including 693 controls, 187 chronic gastritis cases and 333 gastric carcinoma cases, to determine the association between the IL8-251 polymorphism and risk of chronic gastritis and gastric carcinoma in the northern Portugal population. We found no significant association between the IL8-251 polymorphism and increased risk of chronic gastritis or gastric carcinoma, in agreement with that reported in other populations of white origin. The retrospective analysis of published data shows that the association between the IL8-251 polymorphism and risk of gastric carcinoma tends to be reproducible in populations of Asian origin. The estimated effect of the polymorphism under analysis was not significantly different in subgroups of gastric carcinoma cases defined by histologic type and anatomic site of the tumours, and by sex and age of the participants. In conclusion our results indicate that although the IL8-251 polymorphism might be a relevant host susceptibility factor for gastric carcinoma development, this association is likely to be ethnic-specific.

[1]  D. Albanes,et al.  Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial , 2006, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[2]  L. Hou,et al.  Interleukin-8 Polymorphisms Are Not Associated with Gastric Cancer Risk in a Polish Population , 2006, Cancer Epidemiology Biomarkers & Prevention.

[3]  A. Hutchinson,et al.  Polymorphisms in Inflammation-related Genes and Risk of Gastric Cancer (Finland) , 2006, Cancer Causes & Control.

[4]  Y. Hirooka,et al.  Interleukin-8 Promoter Polymorphism Increases the Risk of Atrophic Gastritis and Gastric Cancer in Japan , 2005, Cancer Epidemiology Biomarkers & Prevention.

[5]  Yi-ping Lin,et al.  The −251T Allele of the Interleukin-8 Promoter Is Associated with Increased Risk of Gastric Carcinoma Featuring Diffuse-Type Histopathology in Chinese Population , 2005, Clinical Cancer Research.

[6]  D. Lin,et al.  Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. , 2005, Carcinogenesis.

[7]  T. Koike,et al.  The polymorphism interleukin 8 −251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population , 2005, Gut.

[8]  S. Chanock,et al.  Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  C. Lopes,et al.  Investigating the effect of nonparticipation using a population-based case-control study on myocardial infarction. , 2004, Annals of epidemiology.

[10]  S. Turner,et al.  Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. , 2003, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[11]  C. Caldas,et al.  A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. , 2003, Gastroenterology.

[12]  J. Goedert,et al.  Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. , 2003, Gastroenterology.

[13]  C. Caldas,et al.  Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. , 2002, Journal of the National Cancer Institute.

[14]  P. Pharoah,et al.  Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. , 2001, Gastroenterology.

[15]  E. El-Omar.  The importance of interleukin 1β inHelicobacter pylori associated disease , 2001 .

[16]  M. Sobrinho-Simões,et al.  Current thoughts on the histopathogenesis of gastric cancer. , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[17]  D. Kwiatkowski,et al.  Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families , 2000, Thorax.

[18]  M. Carrington,et al.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.

[19]  C. Pusey,et al.  Long-term sequelae of Helicobacter pylori gastritis , 1995, The Lancet.

[20]  François Rousset,et al.  GENEPOP (version 1.2): population genetic software for exact tests and ecumenicism , 1995 .

[21]  C. N. Leitão,et al.  Anti‐Helicobacter pylori antibodies prevalence and gastric adenocarcinoma in Portugal: report of a case‐control study , 1993, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[22]  J. Parsonnet.  Helicobacter pylori and gastric cancer. , 1993, Gastroenterology clinics of North America.

[23]  P. Correa,et al.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.

[24]  G. Friedman,et al.  Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.

[25]  M. Salimans,et al.  Rapid and simple method for purification of nucleic acids , 1990, Journal of clinical microbiology.

[26]  R. P. Blankfield,et al.  Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.

[27]  K. Bodger,et al.  Helicobacter pylori and gastric inflammation. , 1998, British medical bulletin.

[28]  M. Stolte,et al.  Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre. , 1996, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[29]  P. Sipponen.  Gastric cancer--a long-term consequence of Helicobacter pylori infection? , 1994, Scandinavian journal of gastroenterology. Supplement.